ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Heat Biologics Inc

Heat Biologics Inc (HTBX)

2.83
0.00
(0.00%)
Closed September 24 4:00PM
2.83
0.00
( 0.00% )
Pre Market: 8:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.83
Bid
2.81
Ask
2.89
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
2.83
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
26,082,000
Dividend Yield
-
PE Ratio
-0.43
Earnings Per Share (EPS)
-1.73
Revenue
7M
Net Profit
-45.22M

About Heat Biologics Inc

Heat Biologics Inc is an immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy and Comb... Heat Biologics Inc is an immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy and Combination Pan-Antigen Cytotoxic Therapy form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically modified, irradiated human cancer cells that secrete tumour-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

HTBX Latest News

Heat Biologics Announces Planned Transfer to the NYSE American

DURHAM, N.C., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023 Reaffirms ANTHIM as an important medical countermeasure in the U.S...

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

DURHAM, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

Designed for rapid “plug and play” programming and stockpiling against emerging infectious agents and viral mutations Emergence of Omicron and other COVID-19 variants underscores the need for a...

Heat Biologics Provides Third Quarter 2021 Business Update

DURHAM, N.C., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), today provided strategic, financial, and operational updates for the third quarter ended September...

Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy

DURHAM, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
$ 1.48
(34.55%)
2.94M
VSMEVS Media Holdings Ltd
$ 1.61
(30.89%)
2.49M
ELYMEliem Therapeutics Inc
$ 8.17
(24.54%)
277.25k
TOIOncology Institute Inc
$ 0.349
(20.10%)
1
STSSSharps Technology Inc
$ 0.2009
(17.83%)
3.97k
VTNRVertex Energy Inc
$ 0.1598
(-55.73%)
1.24M
PLBYPLBY Group Inc
$ 0.53
(-26.40%)
74
SFIXStitch Fix Inc
$ 2.80
(-25.33%)
28.54k
PTIXProtagenic Therapeutics Inc
$ 0.46
(-23.46%)
15
NRSNNeuroSense Therapeutics Ltd
$ 1.01
(-19.20%)
635
ELABElevai Labs Inc
$ 0.1102
(6.99%)
5.09M
MTCMMTec Inc
$ 0.2813
(-1.51%)
2.96M
MSGMMotorsport Games Inc
$ 1.48
(34.55%)
2.94M
VSMEVS Media Holdings Ltd
$ 1.61
(30.89%)
2.49M
SQQQProShares UltraPro Short QQQ
$ 7.58
(-0.92%)
1.24M

Discussion

View Full Feed
CarlCarlMcB CarlCarlMcB 2 minutes ago
Reeling $$$$$ whale on $$$$$$$$
AGRI
TrendTrade2016 TrendTrade2016 3 minutes ago
THE OTC DECIMATION IS ENTERING INTO THE FINAL PHASE OF THE BIGGEST OTC INSIDER SELLING PHASE ITS EVER SEEN AND THE NEXT 6 WEEKS IS GOING TO ROCK THE CLOWN CIRCUS LIKE WE HAVE NEVER SEEN
Penny2Dime Penny2Dime 4 minutes ago
Great!
BDPT
ITYS ITYS 5 minutes ago
MWWC issues more conversion shares than it is authorized to, it breaches compliance with securities laws. --ouch

If an OTC (Over-the-Counter) company issues more conversion shares than it is authorized to, it breaches compliance with securities laws. Here are some potential consequenc
MWWC
TrendTrade2016 TrendTrade2016 5 minutes ago
WE ARE DAYS AWAY FROM THE BEGINNING OF THE MARKET CORRECTION AND ANYONE CALLING THE MARKET CONTINUATION IS A CLOWN
Juntao Juntao 5 minutes ago
$AUTR https://www.otcmarkets.com/stock/AUTR/security
AUTR
Money hunt Money hunt 7 minutes ago
Take out the news
FOXO
Money hunt Money hunt 9 minutes ago
We need news FOXO AI
FOXO
sctts sctts 10 minutes ago
$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
floblu14 floblu14 10 minutes ago
From my July 27, 2024 post -

FWIW -

It still is a big IF that ENTA wins summary judgment against PFIZER. Even a mediated settlement is quite positive.

Back in June of 2022, RBC Capital Markets analyst Brian Abrahams states -

"A typical roya
ENTA
eagle8 eagle8 11 minutes ago
Thanks for this interesting post ATL.
It would be something if the CI (with still very nasty side effects) could be replaced by vitamin C.

GLTU
NWBO
ITYS ITYS 11 minutes ago
Its pretty simple to read and understand. How you feel Williams is in middle makes no sense, your not even good at distorting the truth lol

FACT CHECK,
Coronacide filed lawsuit against Wellness Matrix

CoronaCide Test Kits
https://cases.justia.com/federal/d
MGON
prototype_101 prototype_101 12 minutes ago
Jeunke said, The Polariton/ Lightwave announcement implies sampling/ scalable production on 200 mm wafers from AMF. Please realize that this can be sold to transceiver companies, but also directly to hyperscalers designing their own solutions like Facebook, Amazon, Google. It forces the complete sup
LWLG
TrendTrade2016 TrendTrade2016 14 minutes ago
clowns and bagholders will be feeling lots of anxiety with this garbage as the weekly takes its hostages
TGRP
ITYS ITYS 17 minutes ago
Yes, you can bid whack but i was referring to actually putting an ask out and getting it hit,
They are selling around the others. Many of the bids/asks are all or none blocks.

Conboy gets 10% royalty, so last Q they posted $108k for 3 months...YA think he is doing all that wor
GEVI
Omar8 Omar8 19 minutes ago
AlwaysRed,






There are still contracts and this month closing fast, will there be a push down ?


https://www.cmegroup.com/markets/metals/precious/silver.volume.html
SLV
TrendTrade2016 TrendTrade2016 19 minutes ago
getting close to destruction as the next tweet demolishes this scam
BIEI
chicks0123 chicks0123 20 minutes ago
Good morning CLNVERS
CLNV
SkeBallLarry SkeBallLarry 22 minutes ago
I'm living in big time fear these days. >

Same here, K2 ... I don't like all I'm hearing " .. !!
WojD40 WojD40 23 minutes ago
From chatGPT on the subject of inspections. I think the Advent license was a major major hurdle.

For MHRA (Medicines and Healthcare products Regulatory Agency) approval, there are several types of inspections that may be required, particularly for advanced therapies like the personali
NWBO
ksquared ksquared 26 minutes ago
Good Morning back atcha, cap. I also read (skim) through the online comments.
It's horrifying how many people jump in to vilify Trump. What the....???
Mon Dieu. I'm living in big time fear these days.
Stay safe.
Money hunt Money hunt 28 minutes ago
Going to the next level, accumulate all you can now, resistance will be tested
RNAZ
Nolis Nolis 28 minutes ago
Time to cover
LWLG
TommyBoyTrader9460 TommyBoyTrader9460 30 minutes ago
$ADHC
https://x.com/autumnsdad1/status/1838875376778424501?s=61
ADHC

Your Recent History

Delayed Upgrade Clock